Michael Makris: Romiplostim Use Allows More Chemotherapy to Be Delivered on Time
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared a post on LinkedIn about a recent article by Hanny Al-Samkari et al, published in The New England Journal of Medicine:
“Romiplostim use allows more chemotherapy to be delivered on time.
A paper in this week’s New England Journal of Medicine by Hanny Al-Samkari and colleagues reports on a double-blind study of Romiplostim vs Placebo for Chemotherapy-induced Thrombocytopenia.
84% of the Romiplostim and 36% of the Placebo group had no chemotherapy dose modifications.
All the patients had solid tumours.
We do not know if administering more chemo results in a survival advantage, since this would have required a larger trial and much longer follow-up.”
Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Authors: Hanny Al‑Samkari, César Muñoz, Çağlayan Geredeli, Ippokratis Korantzis, Beatriz González Astorga, Cagatay Arslan, Johnny Francisco Cordeiro Camargo, Florian Scotté, Giuliano Borges, Kejia Wang, Melissa Eisen, David J. Kuter, Gerald A. Soff
Read the Full Article on The New England Journal of Medicine
Other articles featuring Michael Makris on Hemostasis Today.
-
Nov 2, 2026, 02:56Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells
-
Nov 2, 2026, 02:45Marija Tashkovska: Advancing Transfusion Medicine Through Collaboration
-
Nov 2, 2026, 02:32Rachel Rosovsky: Pulmonary Embolism During Pregnancy and Postpartum
-
Nov 2, 2026, 02:26Jaromir Vajter: Bleeding Risks and Anticoagulation After ECPR
-
Nov 2, 2026, 02:13Maia Meier: 111 Kilometres on Skis to the South Pole
-
Nov 1, 2026, 23:49Austin Reese: Should Anticoagulation for AF Continue When Patients Move into Long-Term Care?
-
Nov 1, 2026, 23:43Abdelmonam Hagag: Mechanical Thrombectomy vs Anticoagulation in Acute Pulmonary Embolism New Meta Analysis
-
Nov 1, 2026, 23:38Ankur Garg: Safe Water and Nutrition as Economic Investments for LMIC Demographic Dividends
-
Nov 1, 2026, 23:30Ana Paula Tagliari: FIH Experience with Penumbra Lightning Flash 2.0 at TCT 2026